'); //--> Back to Boston.com homepage Arts | Entertainment Boston Globe Online Cars.com BostonWorks Real Estate Boston.com Sports digitalMass Travel

Top Ten
1. Charles River Labs
2. TJX
3. Perini
4. Investors Fin. Svcs.
5. Gillette
6. Staples
7. OneSource
8. Reebok
9. Bright Horizons
10. State Street
2002 Globe 100

Year's Best
Company of year
Highest market value
Highest sales
Comeback of the year
Biggest stock gain
Fastest growth

Overall performance
Bulls and Bears
  1. Clean Harbors
  2. Hologic
  3. NMT Medical
  4. DeWolfe
  5. Indevus Pharm.
  1. Sonus Networks
  2. Art Tech. Group
  3. Praecis Pharm.
  4. American Tower
  5. Dusa Pharmaceutical
Market value
Medical devices
  1. Cytyc
  2. Polymedica Corp.
  3. Perini
  4. Tweeter
  5. Boston Private Fin.
Company profiles
Globe 100 notes

Get the chart
The 2002 Globe 100
All the charts

Sections Boston Globe Online: Page One Nation | World Metro | Region Business Sports Living | Arts Editorials

Search the Globe:


The Boston Globe OnlineBoston.com The Best in Massachusetts Business
2.  P O L Y M E D I C A   C O R P .

Sales of glucose test strips invigorate Woburn firm

    Globe 100
  1. Cytyc
  2. Polymedica Corp.
  3. Perini
  4. Tweeter
  5. Boston Private Financial

Get the chart
   The Growth 50
   Revenue growth
   All the charts

Polymedica is sitting atop an enormous growth market: diabetes.

The Woburn firm began selling glucose test strips directly to diabetes patients in 1998 when a change in Medicare rules made it possible for patients to be reimbursed for their supplies. Such test strips now account for more than three-quarters of Polymedica's revenues, which surged from $73.8 million in 1998 to $220 million in its fiscal 2001, which ended March 30. For calendar 2001, revenues were $263.6 million.

The company claims to have 484,000 patients it serves with home supplies for the treatment of diabetes and other diseases, and a total of 1.2 million patients in its database. It pulls in more with television ads featuring Wilford Brimley, the crotchety actor who once exhorted Americans to eat their oatmeal on behalf of Quaker Oats. The ads have become such a fixture they were recently spoofed on "Saturday Night Live. "

Meanwhile, diabetes marches on: Type 2 diabetes, which accounts for more than 90 percent of all cases, climbed 33 percent over the past 10 years, according to the Centers for Disease Control, and now afflicts 17 million people in the United States.

"We never run out of patients," said Steven J. Lee, the firm's chairman and chief executive. "There's 800,000 to 1 million new patients a year."

Polymedica has plans to drive continued growth. It is selling additional products and services to its enormous customer base, such as prescription medications and therapeutic shoes. That also leverages Polymedica's proprietary customer service software, which juggles hundreds of specialized products and handles billing with thousands of insurance companies.

The firm, which employs 60 in a Massachusetts manufacturing facility but has most of its operations in Florida, is also planning to open a laboratory to process diagnostic tests for diabetes patients -- another way to generate additional revenue from its customer base.

With the growth have come some serious questions. The Securities and Exchange Commission conducted a formal inquiry into the firm's finances. The commission closed the investigation without taking any action in April, leading to a surge in Polymedica's share price.

Polymedica also faces an ongoing investigation by the US Department of Justice, which is looking at allegations of health-care fraud by the company's Liberty Medical Supply Co. and Liberty Home Pharmacy Corp. Since seizing records last summer, the Justice Department hasn't contacted the company, Lee said.

"At this point I can honestly say the government has not told us that we've done anything wrong," he said.


© Copyright 2002 Boston Globe Electronic Publishing Inc.
| Advertise | Contact us | Privacy policy |

Sponsors of the Globe 100 breakfast